Y-pegylated recombinant interferon alpha-2a (Xiamen Amoytop Biotech)
Y型PEG化重组人干扰素α2a（厦门特宝）
Report date: 2026/05/22 20:01:29
Base Information
Drug NameY-pegylated recombinant interferon alpha-2a (Xiamen Amoytop Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXiamen Amoytop Biotech Co LtdBiogeneric Pharma
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesBiogeneric PharmaXiamen Amoytop Biotech Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A